Effect of an oral contraceptive containing drospirenone and ethinylestradiol on general well-being and fluid-related symptoms

被引:72
作者
Apter, D
Borsos, A
Baumgärtner, W
Melis, GB
Vexiau-Robert, D
Colligs-Hakert, A
Palmer, M
Kelly, S
机构
[1] Vaestoliitto Family Federat Finland, Helsinki 00101, Finland
[2] Univ Debrecen, Med & Hlth Sci ctr, Clin Gynecol & Obstet, Debrecen, Hungary
[3] Univ Studi Osped, Inst Obstet & Gynecol, Cagliari, Italy
[4] Schering AG, Outcomes Res Dept, D-1000 Berlin, Germany
[5] Schering Hlth Clin Ltd, Dept Med, Burgess Hill, England
关键词
drospirenone; ethinylestradiol; well-being; oral contraceptives; Psychological General Well-Being Index; abdominal bloating; breast tension; blood pressure; heart rate; body weight; somatic symptoms; quality of life;
D O I
10.1080/713604397
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Oral contraception is the most widely used reversible contraceptive method. Continuous research over the past decades has led to a range of highly reliable, effective and safe oral contraceptives. Newly developed progestogens may also provide additional non-contraceptive health-related benefits that differentiate the products from each other. Women desiring contraception may thus choose from a wide range of oral contraceptives according to their individual needs. A variety of physical and emotional changes have been linked to hormonal fluctuations during the menstrual cycle. To date, only very few studies have been performed on the impact of fluid retention-related symptoms on well-being and few data are hence available on suggested methods of measurement. This open, multicenter, uncontrolled study evaluated the effects of a combined preparation containing 3 mg drospirenone and 30 mug ethinylestradiol (Yasmin(R), Schering AG, Berlin, Germany) on general well-being and fluid-related symptoms in women experiencing psychological, behavioral and somatic premenstrual symptoms. The study was conducted over six 28-day cycles, with 336 subjects enrolled. A significant beneficial effect on psychological general well-being, as measured by the Psychological General Well-Being Index (PGWBI), was evident by cycle 3 and maintained at cycle 6. There was a significant reduction in both the incidence and severity of somatic symptoms associated with the menstrual cycle (abdominal bloating and breast tension) during treatment. Assessment by the investigator showed that 80% of subjects had improved on study treatment and 75% of subjects considered themselves satisfied with the study treatment. There was good agreement between the clinician and subject in their assessment of the treatment. Cycle control was very good and body weight remained stable or decreased slightly during the study. In conclusion, 3 mg drospirenone in combination with 30 mug ethinylestradiol has been shown to have a beneficial effect on psychological general well-being, as measured by the PGWBI. Reductions in the incidence and severity of somatic symptoms associated with the menstrual cycle were also observed, suggesting a beneficial effect due to the anti mineralocorticoid nature of drospirenone. To our knowledge, this is the first study on oral contraceptives which has used the PGWBI in this population. As quality of life is one of the least explored segments in oral contraceptive users, more studies should investigate the impact of oral contraceptives on quality of life and general well-being in this overall healthy population.
引用
收藏
页码:37 / 51
页数:15
相关论文
共 50 条
  • [41] Evaluation of efficacy, safety and effects on symptoms of androgenization of a generic oral contraceptive containing chlormadinone acetate 2 mg/ethinylestradiol 0.03 mg
    Hadji, Peyman
    Biskup, Jutta
    Boekhoff, Jelena
    Ziller, May
    Bonn, Michael
    Rovati, Lucio
    CONTRACEPTION, 2012, 86 (04) : 359 - 365
  • [42] The oral contraceptive containing 30 μg of ethinylestradiol plus 3 mg of drospirenone is able to antagonize the increase of extracellular water occurring in healthy young women during the luteal phase of the menstrual cycle:: an observational study
    Fruzzetti, Franca
    Lello, Stefano
    Lazzarini, Veronica
    Fratta, Stefania
    Orru, Marisa
    Sorge, Roberto
    Minerba, Luigi
    Ricci, Cabiria
    Genazzani, Andrea Riccardo
    Melis, Glan Benedetto
    Paoletti, Anna Maria
    CONTRACEPTION, 2007, 75 (03) : 199 - 203
  • [43] Measuring individual and work-related correlates of employees' well-being with a short form of the psychological general well-being index: A pilot validation study in Slovenia
    Hvalic-Touzery, Simona
    Babnik, Katarina
    Pivac, Sanela
    Skela-Savic, Brigita
    HUMAN SYSTEMS MANAGEMENT, 2020, 39 (02) : 265 - 275
  • [44] Burden of Oral Symptoms and Its Associations With Nutrition, Well-Being, and Survival Among Nursing Home Residents
    Lindroos, Eeva K.
    Saarela, Riitta K. T.
    Suominen, Merja H.
    Muurinen, Seija
    Soini, Helena
    Kautiainen, Hannu
    Pitkala, Kaisu H.
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2019, 20 (05) : 537 - 543
  • [45] Suppression of ovarian activity with a low-dose 21/7-day regimen oral contraceptive containing ethinylestradiol 20 mcg/drospirenone 3 mg in Japanese and Caucasian women
    Anzai, Yuzuru
    Heger-Mahn, Doris
    Schellschmidt, Ilka
    Marr, Joachim
    CONTRACEPTION, 2012, 86 (01) : 28 - 34
  • [46] Effect of an oral contraceptive preparation containing ethinylestradiol and gestodene on CYP3A4 activity as measured by midazolam 1′-hydroxylation
    Palovaara, S
    Kivistö, KT
    Tapanainen, P
    Manninen, P
    Neuvonen, PJ
    Laine, K
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 50 (04) : 333 - 337
  • [47] The effect of nature exposure, nature connectedness on mental well-being and ill-being in a general Chinese population
    Liu, Hongxiao
    Nong, Huifu
    Ren, Hai
    Liu, Ke
    LANDSCAPE AND URBAN PLANNING, 2022, 222
  • [48] The effect of physical and psychological symptoms on spiritual well-being and emotional distress in inpatient cancer patients
    Aktas, Alev
    Ugur, Ozlem
    SUPPORTIVE CARE IN CANCER, 2023, 31 (08)
  • [49] A Randomized Controlled Trial of a Low-Dose Combined Oral Contraceptive Containing 3 mg Drospirenone Plus 20 μg Ethinylestradiol in the Treatment of Acne Vulgaris: Lesion Counts, Investigator Ratings and Subject Self-Assessment
    Maloney, J. Michael
    Dietze, Peter, Jr.
    Watson, David
    Niknian, Minoo
    Lee-Rugh, Sooji
    Sampson-Landers, Carole
    Korner, Paul
    JOURNAL OF DRUGS IN DERMATOLOGY, 2009, 8 (09) : 837 - 844
  • [50] Effects of a Strengths Intervention on General and Work-Related Well-Being: The Mediating Role of Positive Affect
    Meyers, Maria Christina
    van Woerkom, Marianne
    JOURNAL OF HAPPINESS STUDIES, 2017, 18 (03) : 671 - 689